Senior (LSE:SNR), the international manufacturer of high-technology components for aerospace, defence and industrial markets, reported adjusted profit before tax up 38% (40% at constant currency) for the half-year ended 30 June compared with the same period last year.
Revenue rose 7% at constant currency, with group operating profit margin reaching double digits at 10.0%, up 170 basis points.
Reported profit before tax swung to a loss after the group booked £39m of costs associated with corporate undertakings, of which £34.7m relate to contingent adviser and employee remuneration costs tied to the Zeus UK Bidco acquisition. Return on capital employed improved 260 basis points to 14.5%, and net debt to EBITDA leverage held steady at 0.9 times, unchanged from the end of 2025.
The Aerospace division delivered growth in order intake, sales and margins, while Flexonics outperformed its end markets, driven by resilience in North American heavy-duty truck demand, according to David Squires, Group Chief Executive Officer.
"The group has performed very strongly in the first half of 2026, making excellent progress towards the achievement of our medium-term targets," Squires said.
Senior shareholders approved the scheme of arrangement for the recommended cash acquisition by Zeus UK Bidco, backed by funds advised by Tinicum Incorporated and Blackstone, with 99.7% of votes in favour on 26 May.
Ten of the twelve required regulatory and antitrust approvals have now been granted, and the company expects completion by the end of 2026.
No interim dividend has been declared, reflecting the cash consideration terms of the pending acquisition.
Full-year expectations remain unchanged from the July post-close trading update.
News Intelligence what this means for the company
Senior reported adjusted profit up 38% in H1 2026 with operating margin expanding 170 basis points to 10.0%, while revenue grew 7% at constant currency—solid operational performance. However, reported profit swung to a loss after £39m in acquisition-related costs, and the pending £2.6bn Blackstone-backed takeover remains contingent on two outstanding regulatory approvals, with completion expected by end-2026. The operational momentum is real, but the deal overhang and near-term earnings distortion from transaction costs limit the investment signal.
The H1 results confirm Senior is executing operationally—margin expansion and ROCE improvement to 14.5% suggest the business is performing toward its medium-term targets. But with the takeover still pending two regulatory approvals and no interim dividend declared due to the cash acquisition terms, near-term shareholder returns are suspended and the outcome remains binary on deal completion by year-end.
Insights assembled by AI. Editor-reviewed and grounded in tickstock’s coverage and proprietary knowledge graph.
Content is for informational purposes only, not financial advice.
